Diffuse Cystic Lung Disease: A Clinical Guide to Recognition and Management

Area of Science:

• Pulmonology
• Radiology
• Genetics

Background:

• Diffuse cystic lung diseases (DCLDs) are a heterogeneous group of conditions characterized by multiple thin-walled pulmonary cysts.
• These diseases differ significantly from typical interstitial lung diseases in their epidemiology, pathogenesis, and treatment.
• Accurate identification of DCLDs is vital due to emerging targeted therapies.

Purpose of the Study:

• To provide a practical framework for evaluating patients with DCLDs.
• To outline current diagnostic and management strategies for common DCLDs.
• To emphasize the importance of a systematic clinical approach for improved case detection.

Main Methods:

• Review of current literature and clinical guidelines for DCLD diagnosis and management.
• Focus on common DCLDs: lymphangioleiomyomatosis, pulmonary Langerhans cell histiocytosis, Birt-Hogg-Dubé syndrome, and lymphoid interstitial pneumonia.
• Emphasis on chest CT imaging and structured assessment of associated clinical factors (medical, social, family history, renal, dermatologic).

Main Results:

• Chest CT is the primary noninvasive diagnostic tool for DCLDs.
• A structured approach integrating clinical history and physical examination findings enhances diagnostic accuracy.
• Specific DCLDs discussed include lymphangioleiomyomatosis, pulmonary Langerhans cell histiocytosis, Birt-Hogg-Dubé syndrome, and lymphoid interstitial pneumonia.

Conclusions:

• While individually rare, DCLDs are collectively more common than often perceived.
• Pulmonologists need increased awareness and a systematic approach to improve DCLD recognition.
• Earlier diagnosis and intervention in DCLDs can reduce patient morbidity and mortality.